Recent research in PNAS highlights advancements in non-viral, cell-specific delivery methods for CRISPR-Cas systems, emphasizing their potential to enhance research and gene therapy applications by minimizing risks associated with off-target effects and improving targeted delivery.
Breakthrough in CRISPR delivery promises safer gene editing
- Thread starter Educator
- Start date